PRESS RELEASE published on 02/06/2024 at 14:01, 1 year 11 months ago MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY Mainz Biomed N.V. (NASDAQ:MYNZ) has established the 'European Oncology Lab' (EOL), a physician-led laboratory for expanding service offering to privately insured patients in Germany. The lab will offer ColoAlert® as a laboratory medical service directly to physicians and patients, addressing the crucial requirement for invoicing private health insurance companies Germany Mainz Biomed N.V. European Oncology Lab ColoAlert Privately Insured Patients
PRESS RELEASE published on 11/09/2023 at 14:01, 2 years 2 months ago Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
PRESS RELEASE published on 11/07/2023 at 14:01, 2 years 2 months ago Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
PRESS RELEASE published on 10/31/2023 at 13:01, 2 years 3 months ago Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
PRESS RELEASE published on 10/26/2023 at 14:01, 2 years 3 months ago Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
PRESS RELEASE published on 10/18/2023 at 14:01, 2 years 3 months ago Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
PRESS RELEASE published on 10/11/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
PRESS RELEASE published on 10/05/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
PRESS RELEASE published on 10/04/2023 at 14:01, 2 years 4 months ago Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
PRESS RELEASE published on 09/27/2023 at 14:01, 2 years 4 months ago Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
Published on 02/05/2026 at 01:35, 4 hours 11 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 5 hours 46 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 7 hours 21 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/04/2026 at 16:15, 13 hours 31 minutes ago Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures
Published on 02/04/2026 at 20:54, 8 hours 52 minutes ago Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Published on 02/04/2026 at 20:36, 9 hours 10 minutes ago EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Published on 02/04/2026 at 20:00, 9 hours 46 minutes ago Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Published on 02/04/2026 at 18:55, 10 hours 51 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/04/2026 at 18:40, 11 hours 6 minutes ago Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology
Published on 02/04/2026 at 18:04, 11 hours 42 minutes ago Capital et droits de vote au 31 janvier 2026
Published on 02/04/2026 at 18:04, 11 hours 42 minutes ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 12 hours 1 minute ago Information concerning the total number of voting rights and shares 2026 01 31
Published on 02/04/2026 at 17:45, 12 hours 1 minute ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
